|Report ID : RNR-77660||Category : Biotechnology||Published Date : April-2019|
|Publisher : Prof Research||Pages : 140||Format : PDF|
The global market size of GMP Cell Banking is $XX million in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million by the end of 2024 with a CAGR of XX% from 2019 to 2024. Global GMP Cell Banking Market Report 2019 - Market Size, Share, Price, Trend and Forecast is a professional and in-depth study on the current state of the global GMP Cell Banking industry. The key insights of the report: 1. The report provides key statistics on the market status of the GMP Cell Banking manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. 2. The report provides a basic overview of the industry including its definition, applications and manufacturing technology. 3. The report presents the company profile, product specifications, capacity, production value, and 2013-2018 market shares for key vendors. 4. The total market is further divided by company, by country, and by application/type for the competitive landscape analysis. 5. The report estimates 2019-2024 market development trends of GMP Cell Banking industry. 6. Analysis of upstream raw materials, downstream demand, and current market dynamics is also carried out 7. The report makes some important proposals for a new project of GMP Cell Banking Industry before evaluating its feasibility. There are 4 key segments covered in this report: competitor segment, product type segment, end use/application segment and geography segment. For competitor segment, the report includes global key players of GMP Cell Banking as well as some small players. At least 11 companies are included: WuXi AppTec Charles River Laboratories International Eurofins Scientific Merck KGaA Lonza Group Ltd SGS Ltd For complete companies list, please ask for sample pages. The information for each competitor includes: Company Profile Main Business Information SWOT Analysis Sales, Revenue, Price and Gross Margin Market Share For product type segment, this report listed main product type of GMP Cell Banking market Mammalian Cell Microbial Cell Insect Cell Others For end use/application segment, this report focuses on the status and outlook for key applications. End users sre also listed. Biopharmaceutical Companies Contract Manufacturing Organizations For geography segment, regional supply, application-wise and type-wise demand, major players, price is presented from 2013 to 2023. This report covers following regions: North America South America Asia & Pacific Europe MEA (Middle East and Africa) The key countries in each region are taken into consideration as well, such as United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc. Reasons to Purchase this Report: Analyzing the outlook of the market with the recent trends and SWOT analysis Market dynamics scenario, along with growth opportunities of the market in the years to come Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and non-economic aspects Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market. Market value (USD Million) and volume (Units Million) data for each segment and sub-segment Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players 1-year analyst support, along with the data support in excel format. We also can offer customized report to fulfill special requirements of our clients. Regional and Countries report can be provided as well.
CHAPTER 1 EXECUTIVE SUMMARY CHAPTER 2 ABBREVIATION AND ACRONYMS CHAPTER 3 PREFACE 3.1 Research Scope 3.2 Research Methodology 3.2.1 Primary Sources 3.2.2 Secondary Sources 3.2.3 Assumptions CHAPTER 4 MARKET LANDSCAPE 4.1 Market Overview 4.2 Classification/Types 4.3 Application/End Users CHAPTER 5 MARKET TREND ANALYSIS 5.1 Introduction 5.2 Drivers 5.3 Restraints 5.4 Opportunities 5.5 Threats CHAPTER 6 INDUSTRY CHAIN ANALYSIS 6.1 Upstream/Suppliers Analysis 6.2 GMP Cell Banking Analysis 6.2.1 Technology Analysis 6.2.2 Cost Analysis 6.2.3 Market Channel Analysis 6.3 Downstream Buyers/End Users CHAPTER 7 LATEST MARKET DYNAMICS 7.1 Latest News 7.2 Merger and Acquisition 7.3 Planned/Future Project 7.4 Policy Dynamics CHAPTER 8 TRADING ANALYSIS 8.1 Export of GMP Cell Banking by Region 8.2 Import of GMP Cell Banking by Region 8.3 Balance of Trade CHAPTER 9 HISTORICAL AND CURRENT GMP CELL BANKING IN NORTH AMERICA (2013-2018) 9.1 GMP Cell Banking Supply 9.2 GMP Cell Banking Demand by End Use 9.3 Competition by Players/Suppliers 9.4 Type Segmentation and Price 9.5 Key Countries Analysis 9.5.1 US 9.5.2 Canada 9.5.3 Mexico CHAPTER 10 HISTORICAL AND CURRENT GMP CELL BANKING IN SOUTH AMERICA (2013-2018) 10.1 GMP Cell Banking Supply 10.2 GMP Cell Banking Demand by End Use 10.3 Competition by Players/Suppliers 10.4 Type Segmentation and Price 10.5 Key Countries Analysis 10.5.1 Brazil 10.5.2 Argentina 10.5.3 Chile 10.5.4 Peru CHAPTER 11 HISTORICAL AND CURRENT GMP CELL BANKING IN ASIA & PACIFIC (2013-2018) 11.1 GMP Cell Banking Supply 11.2 GMP Cell Banking Demand by End Use 11.3 Competition by Players/Suppliers 11.4 Type Segmentation and Price 11.5 Key Countries Analysis 11.5.1 China 11.5.2 India 11.5.3 Japan 11.5.4 South Korea 11.5.5 ASEAN 11.5.6 Australia CHAPTER 12 HISTORICAL AND CURRENT GMP CELL BANKING IN EUROPE (2013-2018) 12.1 GMP Cell Banking Supply 12.2 GMP Cell Banking Demand by End Use 12.3 Competition by Players/Suppliers 12.4 Type Segmentation and Price 12.5 Key Countries Analysis 12.5.1 Germany 12.5.2 France 12.5.3 UK 12.5.4 Italy 12.5.5 Spain 12.5.6 Belgium 12.5.7 Netherlands 12.5.8 Austria 12.5.9 Poland 12.5.10 Russia CHAPTER 13 HISTORICAL AND CURRENT GMP CELL BANKING IN MEA (2013-2018) 13.1 GMP Cell Banking Supply 13.2 GMP Cell Banking Demand by End Use 13.3 Competition by Players/Suppliers 13.4 Type Segmentation and Price 13.5 Key Countries Analysis 13.5.1 Egypt 13.5.2 Iran 13.5.3 Israel 13.5.4 South Africa 13.5.5 GCC 13.5.6 Turkey CHAPTER 14 SUMMARY FOR GLOBAL GMP CELL BANKING (2013-2018) 14.1 GMP Cell Banking Supply 14.2 GMP Cell Banking Demand by End Use 14.3 Competition by Players/Suppliers 14.4 Type Segmentation and Price CHAPTER 15 GLOBAL GMP CELL BANKING FORECAST (2019-2023) 15.1 GMP Cell Banking Supply Forecast 15.2 GMP Cell Banking Demand Forecast 15.3 Competition by Players/Suppliers 15.4 Type Segmentation and Price Forecast CHAPTER 16 ANALYSIS OF GLOBAL KEY VENDORS 16.1 WuXi AppTec 16.1.1 Company Profile 16.1.2 Main Business and GMP Cell Banking Information 16.1.3 SWOT Analysis of WuXi AppTec 16.1.4 WuXi AppTec GMP Cell Banking Sales, Revenue, Price and Gross Margin (2014-2019) 16.2 Charles River Laboratories International 16.2.1 Company Profile 16.2.2 Main Business and GMP Cell Banking Information 16.2.3 SWOT Analysis of Charles River Laboratories International 16.2.4 Charles River Laboratories International GMP Cell Banking Sales, Revenue, Price and Gross Margin (2014-2019) 16.3 Eurofins Scientific 16.3.1 Company Profile 16.3.2 Main Business and GMP Cell Banking Information 16.3.3 SWOT Analysis of Eurofins Scientific 16.3.4 Eurofins Scientific GMP Cell Banking Sales, Revenue, Price and Gross Margin (2014-2019) 16.4 Merck KGaA 16.4.1 Company Profile 16.4.2 Main Business and GMP Cell Banking Information 16.4.3 SWOT Analysis of Merck KGaA 16.4.4 Merck KGaA GMP Cell Banking Sales, Revenue, Price and Gross Margin (2014-2019) 16.5 Lonza Group Ltd 16.5.1 Company Profile 16.5.2 Main Business and GMP Cell Banking Information 16.5.3 SWOT Analysis of Lonza Group Ltd 16.5.4 Lonza Group Ltd GMP Cell Banking Sales, Revenue, Price and Gross Margin (2014-2019) 16.6 SGS Ltd 16.6.1 Company Profile 16.6.2 Main Business and GMP Cell Banking Information 16.6.3 SWOT Analysis of SGS Ltd 16.6.4 SGS Ltd GMP Cell Banking Sales, Revenue, Price and Gross Margin (2014-2019) 16.7 ViruSure GmbH 16.7.1 Company Profile 16.7.2 Main Business and GMP Cell Banking Information 16.7.3 SWOT Analysis of ViruSure GmbH 16.7.4 ViruSure GmbH GMP Cell Banking Sales, Revenue, Price and Gross Margin (2014-2019)